Cormorant Reports a $10.4 Million EYPT Purchase

From the Desk of Steve Strazza and Alfonso Depablos

The most significant insider transaction on today’s list is a Form 4 filing by Cormorant Asset Management LP.

The hedge fund reported a purchase of $10.4 million in EyePoint Pharmaceuticals Inc $EYPT.

Here’s The Hot Corner, with data through April 22, 2024:

In another Form 4, Coliseum Capital Management LLC revealed a purchase of $2,228,397 in MasterCraft Boat Holdings Inc $MCFT.

Stay tuned. We’ll be back on Wednesday with more insider activity.

Sign up for The Hot Corner to have these insider transactions e-mailed to you every Monday through Friday.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

The post Cormorant Reports a $10.4 Million EYPT Purchase appeared first on All Star Charts.